検索 条件検索
wx_img
Inquiry Form
  1. Home
  2. Relacorilant

Relacorilant

Corcept completes enrollment in phase 3 Gradient trial of Relacorilant in patients with Adrenal Cushing’s Syndrome. Cushing's disease or hypercortisolism is a rare endocrine disorder that occurs when a pituitary adenoma makes excessive cortisol. Cortisol exerts its functions by binding to the glucocorticoid receptor (GR).
Relacorilant is a selective glucocorticoid receptor modulator (SGRM) in clinical development to prevent the effects of high cortisol. Relacorilant is being studied in various serious disorders, including ovarian, adrenal and prostate cancer and Cushing’s syndrome.

1-tert-Butyl 3-methyl 4-oxopiperidine-1,3-dicarboxylate
1-tert-Butyl 3-methyl 4-oxopiperidine-1,3-dicarboxylate
CM101967
161491-24-3
(R)-2-tert-Butyl 8a-methyl 6-oxo-3,4,6,7,8,8a-hexahydroisoquinoline-2,8a(1H)-dicarboxylate
(R)-2-tert-Butyl 8a-methyl 6-oxo-3,4,6,7,8,8a-hexahydroisoquinoline-2,8a(1H)-dicarboxylate
CM229457
445312-74-3
1-Methyl-1H-pyrazole-4-sulfonyl chloride
1-Methyl-1H-pyrazole-4-sulfonyl chloride
CM188010
288148-34-5
(4-Fluorophenyl)hydrazine hydrochloride
(4-Fluorophenyl)hydrazine hydrochloride
CM255168
823-85-8
4-(Trifluoromethyl)pyridine
4-(Trifluoromethyl)pyridine
CM120878
3796-24-5
(R)-6-tert-Butyl 4a-methyl 1-(4-fluorophenyl)-4a,5,7,8-tetrahydro-1H-pyrazolo[3,4-g]isoquinoline-4a,6(4H)-dicarboxylate
(R)-6-tert-Butyl 4a-methyl 1-(4-fluorophenyl)-4a,5,7,8-tetrahydro-1H-pyrazolo[3,4-g]isoquinoline-4a,6(4H)-dicarboxylate
CM227405
864972-21-4